Glutamate is involved in cerebral ischemic injury, but its role has not been completely clarified and studies are required to understand how to minimize its detrimental effects, contemporarily boosting the positive ones. In fact, glutamate is not only a neurotransmitter, but primarily a key metabolite for brain bioenergetics. Thus, we investigated the relationships between glutamate and brain energy metabolism in an in vivo model of complete cerebral ischemia of 15 min and during post-ischemic recovery after 1, 24, 48, 72, and 96 h in 1-year-old adult and 2-year-old aged rats. The maximum rates (V max ) of glutamate dehydrogenase (GlDH), glutamate-oxaloacetate transaminase, and glutamate-pyruvate transaminase were assayed in somatic mitochondria (FM) and in intra-synaptic 'Light' mitochondria and intra-synaptic 'Heavy' mitochondria ones purified from cerebral cortex, distinguishing post-and pre-synaptic compartments. During ischemia, none of the enzymes were modified in adult animals. In aged ones, glutamate-oxaloacetate transaminase was increased in FM and GlDH in intra-synaptic 'Heavy' mitochondria, stimulating glutamate catabolism. During post-ischemic recovery, FM did not show modifications at both ages while, in intra-synaptic mitochondria of adult animals, glutamate catabolism was increased after 1 h of recirculation and decreased after 48 and 72 h, whereas it remained decreased up to 96 h in aged rats. These results, with those previously published about Krebs' cycle and Electron Transport Chain (Villa et al., [2013] Neurochem. Int. 63, 765-781), demonstrate that: (i) V max of energy-linked enzymes are different in the various cerebral mitochondria, which (ii) respond differently to ischemia and post-ischemic recovery, also (iii) with respect to aging.
Glutamate is the most widely distributed amino acid in the CNS and it is known to be involved in molecular mechanisms of ischemic brain injury. At first, glutamate was hypothesized to exert detrimental effects through the so-called excitotoxicity, that is, the rapid and massive release of glutamate from neurons, coupled to its inhibited reuptake, as a result of energy failure in cerebral ischemia (Rothman and Olney 1986) .
Starting from this theory, NMDA glutamate receptor antagonists were proposed as a therapeutic strategy for brain stroke. However, these drugs failed to show efficacy in clinical trials, likely because glutamate extracellular concentrations peak within 30 min from the stroke onset (M€ uldner and Hoyer 1997; Dirnagl et al. 1999) . After this period, glutamate would otherwise exert its physiological functions, such as the regulation of neurogenesis, synaptogenesis, and neuronal repair (Mattson 2008) . Therefore, the role of glutamate in cerebral ischemia has not been completely clarified yet and further studies are required to understand how to minimize its detrimental effects, contemporarily boosting the positive ones (Moretti et al. 2015a; Bivard et al. 2016; Castillo et al. 2016; Kim et al. 2017; Rink et al. 2017) . In this perspective, glutamate should be studied from a different point of view, because it is not only a neurotransmitter, but primarily a key metabolite for brain bioenergetics (Cooper 2012; Villa et al. 2013a; Ferrari et al. 2015a; Parpura et al. 2017) . In fact, glutamate links the Krebs' cycle with ammonia detoxification and it is a reservoir of carbon atoms to be inserted in the intermediate metabolism through anaplerotic reactions, controlling the motility of -NH 2 moiety of amino acids (Fig. 1 ).
All these metabolic cycles are modified after the ischemic insult (Villa et al. 2009 (Villa et al. , 2013b : energy production is severely damaged because the cerebral blood flow is suddenly interrupted and, consequently, the brain consumes Krebs' cycle intermediates and stimulates anaplerotic reactions in the attempt to sustain adenosine triphosphate (ATP) production because of its lack of energy reserves (Hoyer and Krier 1986 ). In addition, glutamatergic neurons rely actually upon ATP to maintain the energy-expensive ion pumps that control neurotransmitter release and uptake Hofmeijer and Van Putten 2012) .
Strong functional changes in the glutamatergic system were reported also during physiological aging, when glutamate release is reduced (Stephens et al. 2011) . Interestingly, oxidative energy metabolism gradually decreases during aging as well, leading to a decreased ability of the brain to cope with stressful and pathological conditions (Saxena 2012) . In this regard, we have previously hypothesized (Villa et al. 2012a ) that the brain bioenergetics progressively goes through different energy states during the aging process: (i) from the homeostatic 'eumetabolomic energy state' of young individuals, when energy production and expenditure are balanced, (ii) the aging brain shifts to a novel homeostatic equilibrium, that is, the 'dismetabolomic energy state', in which the tissue is susceptible to potential pathological alterations (as in ischemic penumbra), (iii) finally evolving into a 'pathometabolomic energy state' in frankly pathological conditions.
Considering that the aging process is one of the main risk factor for cerebral ischemia (Lee et al. 2011; Moretti et al. 2015b) , the metabolic neuronal damage and the possibility of recovery after stroke primarily defines neurological deficits, above all in aged patients. In fact, cellular integrity from a morphological and functional point of view highly depends on energy metabolism and on the neuronal availability of ATP and creatine phosphate (Siesj€ o 1984) .
Given these premises, in this study, we systematically investigated the relationships between glutamate and brain energy metabolism after complete cerebral ischemia and during post-ischemic recovery at different times (1, 24, 48, 72 , and 96 h) on the cerebral cortex of 1-year-old and 2-yearold male Wistar rats, taking into account the age factor. In fact, the brain tissue responds differently to the ischemic injury at various recovery times, as demonstrated by morphologic studies (Ito et al. 1975; Pulsinelli et al. 1982; Petito and Pulsinelli 1984) and by the modifications in cerebral blood flow (K agstr€ om et al. 1983) .
The maximal rate (V max ) of enzyme activities involved in glutamate and related amino acids metabolism were evaluated, as indicative functional parameters of the brain tissue ability to respond (i) to pathological insults and (ii) to pharmacological treatments (Villa et al. 2012b; Ferrari et al. 2015b) . Moreover, (iii) enzyme activities may be the direct molecular targets of drugs (Villa and Gorini 1997; Villa et al. 2012b Villa et al. , 2016 Villa et al. , 2017a Moretti et al. 2015a) . In this regard, the evaluation of catalytic enzyme activities provides a great advantage over the assay of metabolite concentrations, because it allows to differentiate between subcellular neuronal compartments (Villa et al. 1989 (Villa et al. , 2012b (Villa et al. , 2013a Villa and Gorini 1991) . In fact, this research was performed on: (i) non-synaptic mitochondria of neuronal perikaryon, in vivo located in the post-synaptic terminal, and (ii) in intrasynaptic 'light' and 'heavy' mitochondria (2 types), in vivo located in the pre-synaptic one.
Thanks to the subcellular resolution of analysis and the comparison with previously obtained results regarding Krebs' cycle and electron transport chain (ETC) enzyme activities in the same experimental settings (Villa et al. 2013b) , this study will give an integrated picture of the role of glutamate in relation to brain bioenergetics during cerebral ischemia and post-ischemic recovery, taking into account both (i) the in vivo neuronal compartmentation and (ii) the timing of glutamate metabolism at different time points of recirculation after stroke.
Materials and methods

Animal care
The experiments were performed on 1-(adult) and 2-year-old (aged) male Wistar rats (450-550 g) provided by the Zentralinstitut f€ ur Versuchstierzucht, Hannover, FRG, RRID:RGD_68115). The experimental protocol was approved by the review committee for animal experimentation of the Medical Faculty of the University of Heidelberg and by the responsible government agency. All efforts were made to minimize the number of animals used and the distress to the animals, in accordance with the ARRIVE guidelines. This study was not pre-registered.
The selection of the animals was established by Fisher and Yates permutation tables (1963) and they were allotted randomly to the respective groups according to simple randomization. The experimental groups were divided as follows: (i) adult (1 year) control aged, adult (1 year) ischemic (duration 15 min) aged 1 year, and five different groups of adult animals (1 year) in which 1, 24, 48, 72, 96 h of post-ischemic recovery were, respectively, allowed. The same division in corresponding groups of animals aged 2 years was performed. So, the total number of groups was 14, each comprising the equal amount of animals (10 animals each), for a total number of animals equals to 140.
Rats are described as 'aged' when their strain has 50% survival rate and their survival curve is rectangular. In male Wistar rats, this point is at the age of 24 months (Hollander et al. 1983) . The duration of complete cerebral ischemia (15 min) was chosen to produce characteristic and long-lasting metabolic alterations. The measures taken to minimize the suffering of the animals included careful monitoring of anesthesia depth during surgery, as discussed below.
Preparative procedures for experimental ischemia A graphical time-line of the study design has been reported in Fig. 2 . Preparative procedures were extensively discussed in previous papers (Villa et al. , 2009 (Villa et al. , 2013b . One week before the ischemia induction, the animals were anesthetized with chloralhydrate (8 mg 9 kg À1 body weight of a 4% solution, i.p.). At the alar foramina of the atlas, both vertebral arteries were exposed and electrocoagulated. Common carotid arteries were exposed as well and threads were wound around without causing vessel damage. The incision was sutured and animals were left quiet for a week, housed three and subsequently two per cage, with free access to food and water under standard cycling and housing conditions (temperature: 22 AE 1°C, relative humidity 60 AE 3%, lighting cycle: 12 h light and 12 h darkness; low noise disturbances). For the induction of ischemia, anesthesia was started with 3.0 vol% halothane, and tracheotomy and intubation were performed. Anesthesia was continued with 1.5% halothane and nitrous oxide/ oxygen 70 : 30. The animals were immobilized with pancuronium bromide (2 mg 9 kg À1 , b.wt.) and artificially ventilated. Femoral arteries and veins were exposed and catheterized (i) to measure arterial blood pressure by means of a blood pressure transducer and a Hellige polygraph and (ii) to sample arterial blood for gas analysis and for measurement of hemoglobin, hematocrit, glucose, and lactate concentrations. Bicarbonate was applied through the venous catheter to maintain acid-base equilibrium if necessary. A sagittal incision of the skull and a skin funnel was made to allow the subsequent freezing of the brain. After this procedure, anesthesia was prolonged with 0.5 vol% halothane and nitrous oxide/oxygen 70 : 30, until steady-state conditions. Halothane application was then stopped and anesthesia was continued with nitrous oxide/ oxygen 70 : 30 only.
Nitrous oxide does not alter either cortical cerebral blood flow or overall glucose utilization in the brain (Dahlgren et al. 1981; Ingvar and Siesj€ o 1982) . Although halothane in low concentration (0.6 vol%) reduced the cerebral metabolic rate of oxygen by 25% (Harp et al. 1976) , glycolytic flux and cerebral energy state remained steady under anesthesia with 1.0 vol% halothane, except for a decrease in glucose concentrations Siesj€ o 1970, 1974) . However, (i) to prevent the influence of halothane on ischemic tissue reported by Smith et al. (1974) and by Michenfelder and Milde (1975) for higher concentrations in monkeys and dogs, (ii) to avoid possible modifications in mitochondrial respiration, and (iii) to manage to perform studies during recovery from ischemia without any anesthetic side effects, halothane anesthesia was discontinued when the steady-state was established in all groups investigated.
Induction of experimental complete cerebral ischemia
A steady-state of arterial normotension (mean arterial blood pressure, MABP: 100-120 mmHg), normocapnia (PaCO 2 : 35-42 mmHg), normoxemia and slight hyperoxemia, respectively (PaO 2 : 100-180 mmHg), and normothermia (body temperature: 37.0-37.5°C) was maintained over 20 min. Thereafter, complete cerebral ischemia was induced for 15 min as described in Villa et al. (2002 Villa et al. ( , 2009 Villa et al. ( , 2013b , by looping the threads previously wound around common carotid arteries. To prevent retrograde perfusion of the brain through the anterior spinal artery, and to perform a reproducible complete and global ischemia, MABP was reduced to 30-40 mmHg by hypovolemic hypotension, inducing a total brain circulatory arrest (Furlow 1982) .
After the ischemic period, the brains were quickly removed and the samples of fronto-parieto-temporal cerebral cortex were immersed in an appropriate isolation medium (see below). Controls of 1-and 2-year-old animals were sham operated 1 week prior to the final experiment. The brains of these animals were removed under the same conditions mentioned above. Animals in which the experimental conditions could not be maintained were excluded.
Recovery after experimental complete cerebral ischemia
In animals destined to recirculation, anesthesia was stopped after 15 min complete cerebral ischemia (see above); blood flow was reestablished in the common carotid arteries and MABP normalized after blood reinfusion. The animals, after the respective ischemic and/or reperfusion periods, were re-anesthetized and their brains were rapidly frozen in situ for biochemical assays; then, the frontoparieto-temporal cerebral cortex was removed and immersed in an appropriate isolation medium at 0-4°C (see after). This procedure allows to preserve not only metabolites, but also the catalytic activity of enzymes, permitting the subfractionation of the cerebral tissue, as previously reported (Villa et al. 1989 (Villa et al. , 2013b (Villa et al. , 2016 (Villa et al. , 2017a Battino et al. 1991) .
Preparation of synaptosomal fraction and non-synaptic mitochondria Non-synaptic ('free') and intra-synaptic (two types) mitochondria were prepared by blinded experimenter from cerebral cortex of single animal by the method of Lai et al. (Lai et al. 1977) , as modified and described in details for analytical evaluations by Villa et al. (Villa et al. 1989; Villa and Gorini 1991) .
The rats were killed as previously indicated and the subsequent procedures were performed at 0-4°C. The samples of fronto-parietotemporal cerebral cortex were immediately placed in the isolation medium made of 0.32 M sucrose (Merck, Darmstadt, Germany), 1.0 mM EDTA-K + (Sigma-Aldrich Company, St. Louis, MO, USA), 10 mM Tris-HCl (Merck), pH 7.4. The homogenate (final volume 5 mL) was obtained with a Teflon-glass homogenizer (Braun S Homogenizer, Melsungen, Germany) by five pestle strokes (total clearance: 0.1 mm), at 800 rpm, with electronic speed control. The homogenate was centrifuged at 3.6 9 10 3 g 9 min (2.37 9 10 7 x 2 t) in a Beckman J2-21 Supercentrifuge (Palo Alto, CA, USA), rotor JA-17 (Galway, Ireland).
The nuclear pellet was washed twice and the three combined supernatants were centrifuged at 288 9 10 3 g 9 min (189.2 9 10 7 x 2 t) to yield the 'crude' mitochondrial pellet, containing synaptosomes as well. This pellet was washed by resuspension in the isolation medium by soft homogenization and was placed on discontinuous Ficoll-sucrose gradients (7.5-12%, w/w). The Ficoll (Pharmacia Biotech, AB Uppsala, Sweden) was previously dissolved in stock solution consisting of 0.32 M sucrose, 50 lM EDTA-K + , 10 mM Tris-HCl, pH 7.4. This gradient was centrifuged at 175.2 9 10 4 g 9 min (123.7 9 10 8 x 2 t) in a OTD-65B Sorvall Ultracentrifuge, rotor AH-650 (Newtown, CT, USA).
After centrifugation, the myelin fraction was sucked off and discarded, while the synaptosomal fraction at the interface of 7.5-12% Ficoll-sucrose was collected by aspiration, diluted threefold with isolation medium and centrifuged at 288 9 10 7 g 9 min (189.2 9 10 7 x 2 t), rotor JA-17. The purified 'free' mitochondrial fraction was resuspended in buffered sucrose solution 0.32 M, pH 7.4, and pelleted at 162.4 9 10 3 g 9 min (106.7 9 10 7 x 2 t); the pellet was then resuspended by soft homogenization in a small volume of 0.32 M sucrose buffered solution (pH 7.4) for the assay of the catalytic activity of enzymes.
Preparation of intra-synaptic mitochondria
The synaptosomal pellet isolated from Ficoll-sucrose gradient, was lysed by resuspension and soft homogenization in 6 mM Tris-HCl, pH 8.1 (Villa et al. 1989) . After osmotic shock, the lysate was centrifuged at 399 9 10 3 g 9 min (262.1 9 10 7 x 2 t) and the pellet obtained from lysed synaptosomes was again resuspended and centrifuged at 192.6 9 10 3 g 9 min (126.5 9 10 7 x 2 t); the obtained pellet was resuspended in a medium (3% w/w Ficoll, 0.12 M mannitol (Merck), 30 mM sucrose, 25 lM EDTA-K + , 5 mM Tris-HCl, pH 7.4) and layered on a Ficoll discontinuous gradient consisting of two layer 4.5% w/w Ficoll in 0.24 M mannitol, 60 mM sucrose, 50 lM EDTA-K + , 10 mM Tris-HCl, pH 7.4 and, at the bottom, 6% w/w Ficoll in the same solution. This gradient was centrifuged at 280.2 9 10 3 g 9 min (197.3 9 10 7 x 2 t), rotor AH-650. At the end of this centrifugation, the upper phase, the 'light' intrasynaptic mitochondrial fraction, was sucked off and pelleted at 166.5 9 10 3 g 9 min (109.4 9 10 7 x 2 t); the pellet of this centrifugation and that from the gradient, the 'heavy' intra-synaptic mitochondrial fraction, were separately resuspended in 0.32 M sucrose buffered solution (pH 7.4) and centrifuged at 162.4 9 10 3 g 9 min (106.7 9 10 7 x 2 t). The washed pellets were finally resuspended in the same washing solution for the assay of enzyme catalytic activities.
Enzyme assays
The purity of the mitochondria obtained by this subfractionation method was previously assessed (Villa et al. 1989 ) evaluating lactate dehydrogenase (Bergmeyer and Bernt 1974a) as a cytoplasmic (or synaptoplasmic) marker, and acetylcholinesterase (Ellman et al. 1961 ) as a synaptic plasma membrane and membrane material marker enzyme.
On the different subcellular mitochondrial fractions, the maximum rate (V max ) of the following enzyme activities was evaluated by blinded experimenter, as previously discussed in detail in Villa et al. (2013a) : glutamate dehydrogenase (L-glutamate: NAD + oxidoreductase deaminating, EC 1.4.1.3) (Sugden and Newsholme 1975) , glutamate-oxaloacetate transaminase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1) (Lai et al. 1977) , glutamatepyruvate transaminase (GPT) (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2) (Bergmeyer and Bernt 1974b) .
The protein concentration of the tested subfractions was determined using crystalline bovine serum albumin as standard (Merck), according to Lowry et al. (1951) .
Enzyme catalytic activities were measured by graphic recordings for at least 3 min in a double beam recorder Spectrophotometer (Perkin-Elmer 554; € Uberlingen, Germany). Each value was calculated from two blind determinations on the same sample and catalytic activities were expressed as specific activities in (lmoles of substrate transformed) 9 min À1 9 (mg of mitochondrial protein)
À1
of the subfraction tested.
Statistical analysis
Because all the obtained data are homoscedastic and fit in the Gauss' normal distribution (Shapiro and Wilk 1965) , according to this experimental design, at first the homogeneity of variance was checked by Bartlett's test, and afterward the two-way homoscedastic ANOVA parametric test was used to evaluate the comparisons of each enzyme activity between: (i) adult and aged animals; (ii) the different mitochondrial populations; (iii) control and ischemic animals; (iv) controls and animals during the selected post-ischemic recovery times. In addition, post hoc tests according to Tukey and Dunnett were used to compare the differences between individual groups, controlling statistical evaluation. The StatPlus version 6 (Walnut, CA, USA) statistical software was employed. The Statistical Quality Control by Shewhart Control Charts was employed for outliers (Kang and Kvam 2012) . Sample size calculations were not employed, but estimated sample and effect sizes were based on our previous studies using treatment groups of a similar size for the evaluation of energy-related metabolite contents and enzyme activities (Hoyer and Krier 1986; Hoyer and Betz 1988; M€ uldner and Hoyer 1997; Villa et al. 2002 Villa et al. , 2006 Villa et al. , 2009 Villa et al. , 2013b .
Results
The obtained results have been reported in Figs 3 and 4 as linear graphs, in this way highlighting the modifications undergone by enzyme activities during the various times of post-ischemic recovery.
The statistical differences between the assayed enzyme activities in the various brain mitochondrial populations and the effects of physiological aging were previously thoroughly evaluated both in control and in ischemic conditions (Villa et al. 2006 (Villa et al. , 2009 . Therefore, in this study, we focused on the effects of post-ischemic recovery on glutamate metabolism during aging, briefly reporting the effects of cerebral ischemia for completeness.
Effects of complete cerebral ischemia in adult and aged animals As regards the enzymes linked to the metabolism of glutamate and related amino acids, none of them has been modified by ischemia (I) compared to the baseline activity (C) in adult animals. On the contrary, in aged animals, the activities of glutamate dehydrogenase and glutamate-oxaloacetate transaminase were increased, respectively, in intrasynaptic 'heavy' mitochondria and in non-synaptic ones by the complete cerebral ischemia lasting 15 min.
Effects of recirculation after 1, 24, 48, 72, and 96 h Glutamate dehydrogenase activity (Fig. 3) remained unchanged in non-synaptic mitochondria of adult animals, while in intra-synaptic 'light' mitochondria the activity decreased both in comparison to the control (C, symbol *) and ischemic values (I, symbol §) at 48 and 72 h of recirculation. Conversely, in intra-synaptic 'heavy' mitochondria, the activity increased only after 1 h of postischemic recovery compared to the control value. In aged animals, glutamate dehydrogenase activity decreased in nonsynaptic perikaryal mitochondria at 72 h during recirculation compared to ischemia (symbol §) and in intra-synaptic 'light' ones at 96 h compared to the control value. The major changes were observed in the enzyme activity of intrasynaptic 'heavy' mitochondria, where glutamate dehydrogenase (GlDH) was severely decreased versus ischemia at 1, 24, 48, 72, 96 h and versus control values after 1, 48, 96 h during post-ischemic recovery.
Glutamate-oxaloacetate transaminase activity (Fig. 3 ) was modified in adult animals only in non-synaptic perikaryal mitochondria, where the activity decreased during recovery at 24, 48, 72, and 96 h versus the ischemic value; in intrasynaptic mitochondria, the activity was unaffected by ischemia and during recirculation both in 'light' and 'heavy' subtypes. In aged rats, glutamate-oxaloacetate transaminase (GOT) activity was decreased during recirculation in nonsynaptic mitochondria only at 72 h versus ischemia, while in intra-synaptic mitochondria the activity was decreased in comparison to both control and ischemic values at 48 h in 'light' mitochondria and at 24 and 48 h in 'heavy' ones.
GPT activity (Fig. 4) decreased in non-synaptic mitochondria of adult animals at 24, 48, and 72 h during recirculation versus ischemia, while it increased significantly versus the control value at 1 h during recovery in both intra-synaptic 'light' and 'heavy' mitochondria. In aged animals, GPT activity was unchanged in non-synaptic and intra-synaptic 'light' mitochondria, but it was severely depressed in intrasynaptic 'heavy' ones at all times of recirculation compared to both control and ischemic values.
GPT activity was also assayed in the presence of Triton-X100 (GPT-Tx) in order to evaluate the 'total activity' released after the fragmentation of mitochondrial membranes (Fig. 4) . In adult animals, this procedure affected this enzyme activity (Fig. 4) only in non-synaptic mitochondria, which differed significantly with respect to control and ischemic values after 1 and 72 h during recirculation. Otherwise, in aged animals, total GPT activity was unaffected in non-synaptic mitochondria but severely decreased in intra-synaptic ones: (i) in the 'light' subtype, GPT-Tx was lower at 1 and 48 h versus control and at 1, 48, and 72 h versus ischemia; (ii) in the 'heavy' subtype, the activity was decreased at all recovery times (except 72 h) in comparison to control values and at 1, 48, and 96 h versus ischemia.
Discussion
Effects of complete cerebral ischemia in adult and aged animals This study is the continuation of an ongoing research and aims at evaluating the effects of post-ischemic recovery on the metabolism of glutamate and related amino acids. To better understand the effects of recirculation on the considered functional parameters, we summarize below the results obtained in acute ischemic conditions (Villa et al. 2009 ).
Overall, GlDH, GOT, and GPT are scarcely affected by ischemia: none of these activities were modified in adult animals, while in aged ones, GlDH was increased in intrasynaptic 'heavy' mitochondria and GOT in non-synaptic ones, being GPT and GPT-Tx unaffected. Glutamate dehydrogenase catalyzes the reversible reaction of (i) glutamate oxidative deamination to a-ketoglutarate or of (ii) a-ketoglutarate reductive amination to glutamate (Fig. 1) ; however, the direction of this reaction in vivo is mainly toward glutamate catabolism, because of its positive DG°' (+30 kJ/mol) (Cooper and Jeitner 2016) . Therefore, the increase in this enzyme activity is indicative of the tentative stimulation of a-ketoglutarate formation to metabolize the excess of glutamate in intra-synaptic 'heavy' mitochondria of aged animals, in turn stimulating the Krebs' cycle (Villa et al. 2013b) . To this purpose, Karaca et al. (2015) observed that in brain-specific GlDH-null mice (CnsGlud1 À/À ), the reduction in glutamate oxidation induces a state of central energy deprivation, with changes in the whole-body energy balance.
As regards GOT, this enzyme mediates the reversible transamination that produces a-ketoglutarate from glutamate at the expenses of oxaloacetate, that is transformed into aspartate (Fig. 1) ; however, in this case, the direction of this reaction is strictly dependent on the various biochemical situations occurring in vivo, because of its near equilibrium DG°' (% 0 kJ/mol) (Villa et al. 2013a) . During cerebral ischemia, aspartate was demonstrated to increase along with glutamate concentrations (Phillis and O'Regan 1996) and therefore GOT equilibrium would be shifted toward glutamate catabolism, increasing the detrimental release of NH 3 . Also Rink et al. (2017) recently pointed out that, in ischemic conditions, glutamate-oxaloacetate transaminase may be primarily involved in glutamate conversion into metabolic fuel, that is, a-ketoglutarate.
However, to discuss the effect of ischemia on this enzyme activity, it is important to contestualize GOT also respect to the modifications occurring in the Krebs' cycle. In fact, in non-synaptic mitochondria of aged animals, GOT was increased by cerebral ischemia together with citrate synthase activity (Villa et al. 2009) , that is, the key metabolic control for the metabolic flux entry within the Krebs' cycle (DG 00 (kJ/ mol) = À31.5), in accordance with previously published studies (Ljunggren et al. 1974; Hoyer and Krier 1986) . In these conditions, the two enzymes enter in competition for oxaloacetate utilization, suggesting that the Borst' cycle (malate-aspartate shuttle) is effective also in the ischemic brain , allowing the maintenance of NADH/NAD + ratio within the non-synaptic mitochondria, which is necessary to sustain the ETC. In fact, also the integrated activity of Complex I-III and of Complex IV of ETC are increased by ischemia in this type of mitochondria of aged animals (Villa et al. 2009 ).
To sum up, 15 min of complete cerebral ischemia induced a stimulation of glutamate catabolism only in aged animals, and through different metabolic pathways in non-synaptic and intra-synaptic 'heavy' mitochondria, coherently with the overall bioenergetics of these mitochondrial subpopulations in ischemic conditions.
Effect of recirculation in adult and aged animals
The results obtained during post-ischemic recovery in adult and aged animals have been reported also as qualitative changes in Tables 1 and 2 with respect to control conditions and the relationships between glutamate and brain energy metabolism (Villa et al. 2013b) . In this way, a clear comparison is possible for the effects of recirculation at the various time points in the three mitochondrial populations.
The subcellular resolution of analysis allows to detect the first important finding, differentiating the effects of postischemic recovery on glutamate metabolism in neuronal soma and synapses. In fact, non-synaptic mitochondria did not show substantial modifications at any time point of recirculation, both in adult and aged animals. Likely, this observation could be linked to the maintenance of the selective permeability barrier provided by mitochondrial membranes in non-synaptic mitochondria. This is confirmed by the selective increase in non-synaptic mitochondria of 'total' GPT activity assayed in the presence of Triton X-100 after 1 and 72 h of recirculation in adult animals (Fig. 4) : this detergent breaks up membranes and allows substrates to freely reach the enzyme active site.
Otherwise, in intra-synaptic mitochondria, some modifications in glutamate-linked enzyme activities were observed, also without Triton X-100 in the assay medium. In adult animals, glutamate dehydrogenase activity was increased in intra-synaptic 'heavy' mitochondria and that of GPT was increased both in 'light' and 'heavy' ones after 1 h of recirculation. The stimulation of the catalytic activities of these enzymes is probably linked to the need of Krebs' cycle metabolic intermediates readily produced through the catabolism of glutamate, that is, a-ketoglutarate. Indeed, glutamate concentrations decrease within 1 h from stroke (M€ uldner and Hoyer 1997; Dirnagl et al. 1999) ; thus, our finding explains, on a functional basis, this previously reported result.
Conversely, after 48 and 72 h, GlDH was decreased in intra-synaptic 'light' mitochondria of adult rats, indicating that the metabolic picture changed during recovery. To this purpose, Kim et al. (2017) have recently proposed to focus on glutamate dehydrogenase as a potential pharmacological target for cerebral ischemia: they demonstrated that activators of this enzyme (2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid and b-lapachone) restored a-ketoglutarate and ATP levels in mice subjected to middle cerebral artery occlusion and reperfusion. However, considering also Krebs' cycle and ETC enzyme activities (Villa et al. 2013b) , our results suggest that glutamate catabolism is no longer necessary because the metabolic needs are slowly normalizing in adult animals, as confirmed by the fact that at 96 h of recovery, the assayed enzyme activities were overall unchanged versus controls. Nevertheless, the pharmacological hypothesis of Kim et al. (2017) could be useful for older individuals.
In fact, in aged animals, the activities of GlDH, GOT, and GPT (also as 'total' activity, GPT-Tx) were decreased from 1 to 96 h of recirculation, particularly in the most metabolically compromised mitochondria, that is, the intra-synaptic 'heavy' ones, as discussed later.
As regards GPT activity, like GOT, the reaction catalyzed by this enzyme operates anaplerotically (CO 2 fixation) by replenishing Krebs' cycle intermediates in the form of aketoglutarate. Therefore, it is of interest to note that also the other energy-linked enzyme activities of Krebs' cycle and ETC did not recover at 96 h of reperfusion in aged animals, unlike adult rats (Villa et al. 2013b) .
In particular, intra-synaptic 'heavy' mitochondria are primarily affected. To this purpose, we have previously characterized biochemically and morphologically this mitochondrial population, reporting that intra-synaptic 'Heavy' mitochondria have many features of aged mitochondria: (i) impairment of mitochondrial function for the continuous damage accumulating on membranes, and (ii) higher content of hydroperoxides (Villa et al. 1989; Battino et al. 2000 Battino et al. , 2002 . As a consequence, we have hypothesized that intrasynaptic 'heavy' mitochondria are the aged 'light' ones, injured by the high metabolic requirements of synapses and waiting to be replaced (Battino et al. 2000) .
Therefore, the different metabolic features of non-synaptic and intra-synaptic 'light' and 'heavy' mitochondria are not because of the isolation method (Villa et al. 1989) , but rather their different in vivo localization in pre-and post-synaptic compartments, that possess different energy requirements (Brand and Nicholls 2011; Nicholls et al. 2015) .
Synapses are in fact subcellular sites with high rates of ATP consumption to support the activities of neurotransmitter transporters and of membrane Na + and Ca 2+ -related ATPase System, that rapidly restore gradients of these ions after synapse activation (Attwell and Laughlin 2001; Rangaraju et al. 2014) . Thus, when neurons do not manage to produce enough ATP (e.g., during aging or in ischemic conditions), synapses are vulnerable to dysfunction and degeneration (Harris et al. 2012) . Consequently, the distinct metabolic profiles of brain mitochondrial populations are not a simple problem of biochemical micro-heterogeneity, but a potential significant factor for tissue responsiveness to pathological insults during aging: many studies have shown that changes in brain energy metabolism cause the development and/or progression of several diseases, subsequently leading to morphological modifications (Nicholls 2004; Small et al. 2011; Saxena 2012; Villa et al. 2012a) .
In accordance with these statements, also the responsiveness to pharmacological treatments is different between presynaptic and post-synaptic compartments, as demonstrated by studies about the pharmacodynamic properties on the brain energy metabolism of L-acetylcarnitine (Gorini et al. 1998 (Gorini et al. , 1999 , CDP-choline (Villa et al. 2012b) , and the antidepressant drugs Desipramine and Fluoxetine (Villa et al. 2016 (Villa et al. , 2017a : the treatments lead to adjustments in the neuronal energetic state, in relation to the energy requirements of pre-and post-synaptic compartments after drug administrations.
In this context, it is interesting the possibility to distinguish between non-synaptic and intra-synaptic mitochondria: this study demonstrated that intra-synaptic mitochondria are those primarily affected during post-ischemic recovery, overall showing a decrease in glutamate catabolism. In this perspective, Bivard et al. (2016) observed in human patients that decreased concentrations of glutamate, detected by magnetic resonance spectroscopy after 24 h from stroke, were associated with poorer National Institute of Health Stroke Scale score: the reperfused penumbra with reduced glutamate concentrations may reflect that this tissue is less viable and less predisposed to recover.
In fact, the different effects on brain mitochondria might be connected to the role of glutamate in boosting synaptic neuroplasticity after the acute phase of brain ischemia and upon recirculation. The restart of ATP synthesis and of ATPase activities allow the recovery of neuronal firing and the release of glutamate from presynaptic terminals. The following activation of NMDA receptors induces the activity of cAMP response elementbinding protein and the increased expression of brain-derived neurotrophic factor (BDNF), which have neuroprotective Table 1 Comparative scheme of the qualitative effects of ischemia and post-ischemic recovery versus control animals on catalytic activities of indicated enzymes evaluated on non-synaptic 'Free' mitochondria (FM) and intra-synaptic 'light' (LM) and 'heavy' (HM) mitochondria from the cerebral cortex of 1-year-old adult male Wistar rats effects (Brassai et al. 2015) and influence the neuronal adaptive responses to bioenergetic challenges as well (Ferrari and Villa 2017) . Cheng et al. (2012) observed that BDNF stimulates mitochondrial biogenesis in cultured embryonic hippocampal neurons and further studies (Su et al. 2014 ) demonstrated that, in hippocampal neurons that have formed synapses, BDNF induces an inhibitory effect on mitochondrial motility, leading to increased numbers of mitochondria in pre-synaptic terminals. On the other hand, mitochondrial biogenesis and motility are essential for the formation of neuronal circuits and for synaptic transmission, because they are necessary to provide the required bioenergetic support for these highly energy consuming processes (Raefsky and Mattson 2017) .
To sum up, this study provided a comprehensive picture of glutamate metabolism during cerebral ischemia and postischemic recovery in relation to the overall bioenergetic features of brain mitochondria, highlighting (i) the key role of subcellular neuronal compartments (soma vs. synapses) and (ii) the importance of taking into account the aging process. Moreover, the assay of enzyme catalytic activities, that is, functional parameters, allowed to explain the acknowledged changes in glutamate concentrations after brain stroke (M€ uldner and Hoyer 1997; Dirnagl et al. 1999) , suggesting that further studies on this key multifaceted metabolite and neurotransmitter are recommended to minimize its detrimental effects and boost the neuroprotective ones (Castillo et al. 2016; Chamorro et al. 2016; Kim et al. 2017; Rink et al. 2017) .
In fact, restoring circulation, energy metabolism, and cerebral functions after brain ischemia is of great importance, and it is necessary to define the proper time window which allows (i) the spontaneous recovery of physiological metabolic functions, but also (ii) the delivery and (iii) the Table 2 Comparative scheme of the qualitative effects of ischemia and post-ischemic recovery versus control animals on catalytic activities of indicated enzymes evaluated on non-synaptic 'Free' mitochondria (FM) and intra-synaptic 'light' (LM) and 'heavy' (HM) mitochondria from the cerebral cortex of 2-year-old aged male Wistar rats.
CS
SDH MDH CI-CIII CII CIII CIV GlDH GOT GPT GPT-Tx responsiveness of the cerebral tissue to neuroprotective drugs. In this perspective, the famous sentence 'time is brain' (Saver 2006) should be revisited in 'timing is brain', for the opportunity of therapeutic strategies during post-ischemic recovery (Villa et al. 2017b (Villa et al. , 2018 .
